US Stock MarketDetailed Quotes

LAZ Lazard

Watchlist
  • 49.790
  • -0.410-0.82%
Trading Jan 8 09:49 ET
4.50BMarket Cap19.30P/E (TTM)

Lazard Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lazard Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 740.009M--
--2024/Q4-- / 783.899M--
Oct 31, 20242024/Q3645.914M / 649.087M--
Jul 25, 20242024/Q2684.642M / 638.743M--
Apr 25, 20242024/Q1746.565M / 687.976M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 740.009M--
--2024/Q4-- / 783.899M--
Oct 31, 20242024/Q3645.914M / 649.087M--
Jul 25, 20242024/Q2684.642M / 638.743M--
Apr 25, 20242024/Q1746.565M / 687.976M--

Unlock Free Earnings Estimates

Lazard Earnings Reports

  • Lazard | 10-Q: Q3 2024 Earnings Report

    Nov 1, 2024 16:37 ET

  • Lazard | 8-K: LAZARD REPORTS THIRD-QUARTER AND NINE-MONTH 2024 RESULTS

    Oct 31, 2024 06:41 ET

  • Lazard | 10-Q: Q2 2024 Earnings Report

    Jul 26, 2024 16:34 ET

  • Lazard | 8-K: LAZARD REPORTS SECOND-QUARTER AND FIRST-HALF 2024 RESULTS

    Jul 25, 2024 06:34 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    eBay
    EBAY
    +11.86%
    Halozyme Therapeutics
    HALO
    +4.89%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +3.68%
    Collegium Pharmaceutical
    COLL
    +2.92%
    Workday
    WDAY
    +1.56%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Hold

    • Buy

      20.00%

    • Hold

      80.00%

    • Sell

      0.00%

    Price Target

    No Data